In a study involving individuals with mild cognitive impairment, supplementation with a ketogenic drink containing medium chain triglyceride (kMCT) twice a day for six months was found to improve cognition and increase plasma ketone response compared to the placebo group. The use of kMCT as a potential treatment for cognitive impairment is promising and warrants further research.